The Gummy Project Announces Grant of Stock Options
– Three Phase 3 Domvanalimab Combination Studies in NSCLC are Ongoing – Gilead Sciences, Inc. (Nasdaq: ...
Read more– Three Phase 3 Domvanalimab Combination Studies in NSCLC are Ongoing – Gilead Sciences, Inc. (Nasdaq: ...
Read moreLithiumDyke 16- The newest spodumene-bearing pegmatite dyke to be discovered on the Zoro property. A total ...
Read moreSAN DIEGO, Sept. 2, 2022 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, ...
Read moreJourdan Resources operates the largest lithium exploration portfolio in Quebec. Its four assets sit on a ...
Read moreFLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage ...
Read more© 2022 TheDailyStock.News